ReviewEndocrine-related cancer2026
Artificial intelligence in pituitary surgery: the path to clinical solutions.
Review in Endocrine-related cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is rapidly moving from conceptual innovation to high-performing algorithms across the pituitary patient pathway, promising benefits to patients, endocrinologists and surgeons alike. Pre-operatively, machine learning applied to facial imaging and natural language processing of electronic health records show potential for earlier identification of pituitary adenomas and timelier referral from primary providers to a specialist endocrinologist. Intraoperatively, computer vision systems have already augmented surgical training but have the potential to become integrated real-time decision support systems. Post-operatively, predictive models may help to forecast complications and longer-term remission, endocrinological outcomes or recurrence. Across these domains, the emergence of large, multimodal datasets, which integrate clinical text, endocrinological investigations, radiological imaging, and intraoperative video, promises further AI improvements, yet the impact of AI on real-world clinical decision-making is less clear and depends as much on implementation processes and clinicians themselves. This review provides an overview of AI technologies for pituitary patients and explores some of the challenges translating them to clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.